Table 1.
Association of ApoE isoforms with COVID-19 outcomes
ApoE isoforms/ populations | ε2 | ε3 | ε4 | |||
---|---|---|---|---|---|---|
C/M | D/M | C/M | D/M | C/M | D/M | |
Asia (N = 15) | 0.458 | 0.226 | 0.0045 (0.689) | 0.0011 (0.757) | 0.0181 (− 0.6) | 0.0078 (− 0.6571) |
Africa (N = 10) | 0.260 | 0.293 | 0.803 | 0.803 | 0.777 | 0.726 |
America (N = 13) | 0.437 | 0.312 | 0.816 | 0.958 | 0.654 | 0.689 |
Europe (N = 27) | 0.946 | 0.765 | 0.112 | 0.048 (0.383) | 0.434 | 0.338 |
Total (N = 66)a | 0.458 | 0.913 | 0.129 | 0.104 | 0.033 (− 0.263) | 0.107 |
Values inside the box are p value. Spearman’s correlation coefficient values (+ for positive correlation and − for negative correlation) are given in parentheses for which a significant p value of < 0.05 is observed
C/M cases/millions, D/M deaths/millions, N number of studies
aInclude additional one data set from Australia